Open access
68
Views
22
CrossRef citations to date
0
Altmetric
Original Research
Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial
Sachio Fushida1 Department of Gastroenterological Surgery, Kanazawa University Hospital, KanazawaCorrespondence[email protected]
, Jun Kinoshita1 Department of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa
, Masahide Kaji2 Department of Surgery, Toyama Prefectural Central Hospital, Toyama
, Katsunobu Oyama1 Department of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa
, Yasuo Hirono3 First Department of Surgery, Fukui University Hospital, Fukui
, Tomoya Tsukada2 Department of Surgery, Toyama Prefectural Central Hospital, Toyama
, Takashi Fujimura4 Department of Surgery, Toyama City Hospital, Toyama, Japan
& Tetsuo Ohta1 Department of Gastroenterological Surgery, Kanazawa University Hospital, Kanazawa
show all
Pages 2353-2358
|
Published online: 25 Jul 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.